Effect of the Variations of S-adenosyl-L-methionine Liver Content on Fat Accumulation and Ethanol Metabolism in Ethanol-intoxicated Rats
Overview
Toxicology
Authors
Affiliations
The protective effect of S-adenosyl-L-methionine against rat liver steatosis induced by chronic ethanol ingestion was investigated. S-Adenosyl-L-methionine given during ethanol treatment prevented steatosis and accelerated recovery from steatosis when given after ethanol withdrawal. It also caused a slight inhibition of blood ethanol consumption in both acutely and chronically intoxicated rats. About 30% inhibition of alcohol dehydrogenase, but not of the microsomal ethanol oxidation system, occurred in rats subjected to acute ethanol toxicity as well as in normal rats as a consequence of S-adenosyl-L-methionine treatment. A comparison between S-adenosyl-L-methionine and pyrazole, as concerns inhibition of ethanol oxidation and fat accumulation, revealed that a greater inhibition of ethanol metabolism by pyrazole was associated with incomplete prevention of steatosis, while a lower inhibition by S-adenosyl-L-methionine was coupled to a complete prevention. Ethanol induced a drastic decrease of reduced glutathione liver content as well as 630 and 133% increases of blood and liver acetaldehyde contents, respectively. S-Adenosyl-L-methionine treatment almost completely reconstituted the liver reduced glutathione pool and caused a large decrease of the liver and blood acetaldehyde contents. 1-Chloro-2,4-dinitrobenzene, which depletes the cellular reduced glutathione, and diethylethanolamine, an inhibitor of the phosphatidylethanolamine methylation, abolished the S-adenosyl-L-methionine-induced modifications of the reduced glutathione, acetaldehyde, and triacylglycerol contents in the liver of ethanol-treated rats. Neither S-adenosyl-L-methionine nor reduced glutathione inhibitors affected the liver acetaldehyde dehydrogenase activity. It is suggested that, although S-adenosyl-L-methionine induced a small inhibition of ethanol metabolism in the liver, its antisteatosic effect could largely depend on its role as a modulator of the reduced glutathione liver content.
Sandoval C, Farias J, Zamorano M, Herrera C Antioxidants (Basel). 2022; 11(3).
PMID: 35326214 PMC: 8945215. DOI: 10.3390/antiox11030564.
Pascale R, Simile M, Calvisi D, Feo C, Feo F Cells. 2022; 11(3).
PMID: 35159219 PMC: 8834208. DOI: 10.3390/cells11030409.
Pascale R, Peitta G, Simile M, Feo F Medicina (Kaunas). 2019; 55(6).
PMID: 31234428 PMC: 6631235. DOI: 10.3390/medicina55060296.
Simile M, Latte G, Feo C, Feo F, Calvisi D, Pascale R Ann Gastroenterol. 2018; 31(5):552-560.
PMID: 30174391 PMC: 6102450. DOI: 10.20524/aog.2018.0288.
Pascale R, Feo C, Calvisi D, Feo F Transl Gastroenterol Hepatol. 2018; 3:36.
PMID: 30050996 PMC: 6044036. DOI: 10.21037/tgh.2018.06.04.